enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Multiple sclerosis drug pipeline - Wikipedia

   en.wikipedia.org/wiki/Multiple_sclerosis_drug...

   A small, short-duration clinical trial [103] with MS patients was conducted at the University of California, San Francisco. In October 2007 data was presented at the European Congress of MS in Prague regarding safety findings of a pilot study of low dose naltrexone therapy in multiple sclerosis by neurological researchers in Milan, Italy. [104]

3. List of therapeutic monoclonal antibodies - Wikipedia

   en.wikipedia.org/wiki/List_of_therapeutic...

   rheumatoid arthritis, Crohn's disease, plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, juvenile idiopathic arthritis, hemolytic disease of the newborn: Adecatumumab [9] mab: human: EpCAM: prostate and breast cancer: Aducanumab [10] Aduhelm: mab: human: Amyloid beta: Y [11] Alzheimer's disease: Afasevikumab [12] mab: human: IL-17A ...

4. New treatment may stop and potentially reverse some nerve ...

   www.aol.com/treatment-may-stop-potentially...

   Multiple sclerosis (MS) is an autoimmune disorder in which the immune system attacks and destroys the myelin sheath of nerve cells. It most commonly strikes people between the ages of 20 and 40.

5. Alemtuzumab - Wikipedia

   en.wikipedia.org/wiki/Alemtuzumab

   Alemtuzumab, sold under the brand names Campath and Lemtrada among others, is a medication used to treat chronic lymphocytic leukemia and multiple sclerosis. [8] In chronic lymphocytic leukemia, it has been used as both a first line and second line treatment. [8] It is given by injection into a vein. [8]

6. Research in multiple sclerosis - Wikipedia

   en.wikipedia.org/wiki/Research_in_multiple_sclerosis

   Research in multiple sclerosis may find new pathways to interact with the disease, improve function, curtail attacks, or limit the progression of the underlying disease. . Many treatments already in clinical trials involve drugs that are used in other diseases or medications that have not been designed specifically for multiple sclero

7. Tocilizumab - Wikipedia

   en.wikipedia.org/wiki/Tocilizumab

   Tocilizumab, sold under the brand name Actemra among others, is an immunosuppressive drug, used for the treatment of rheumatoid arthritis, systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, giant cell arteritis, cytokine release syndrome, COVID‑19, and systemic sclerosis-associated interstitial lung disease (SSc-ILD).